Compound information
- Natural Products
- ZC674123
- Molecular Formula
- C19H27N3O5
- Molecular Weight
- 377.195070964 g/mol
- Structure
-
- IUPAC Name
- (2S)-1-[(2S)-6-amino-2-(benzyloxycarbonylamino)hexanoyl]pyrrolidine-2-carboxylic acid
- InChI
- InChI=1S/C19H27N3O5/c20-11-5-4-9-15(17(23)22-12-6-10-16(22)18(24)25)21-19(26)27-13-14-7-2-1-3-8-14/h1-3,7-8,15-16H,4-6,9-13,20H2,(H,21,26)(H,24,25)/t15-,16-/m0/s1
- InChI Key
- SCIBOUZRPFCBFX-HOTGVXAUSA-N
- SMILES
- NCCCC[C@H](NC(=O)OCc1ccccc1)C(=O)N1CCC[C@H]1C(=O)O
- Source
- ZINC000013544334
Warheads
- Carbamate
-
ADMET Property
Physicochemical Property
Property | Value | Property | Value |
---|---|---|---|
Heavy Atom Count | 27 | Ring Count | 2 |
Heteroatom Count | 8 | Rotatable Bond Count | 9 |
Hydrogen Bond Acceptor Count | 5 | Hydrogen Bond Donor Count | 3 |
Topological Polar Surface Area | 121.96 Å2 | LogP | -0.468 |
LogS | -1.685 | LogD | -0.172 |
Absorption
Property | Value | Property | Value |
---|---|---|---|
Pgp inhibitor | 0.003 | Pgp substrate | 0.915 |
HIA | 0.001 | F20 % | 0.992 |
F30 % | 0.076 | Caco-2 | -6.247 |
MDCK | -5.904 |
Distribution
Property | Value | Property | Value |
---|---|---|---|
BBB Penetration | 0.138 | PPB | 62.691 |
VD | 0.716 | Fu | 0.216 |
Metabolism
Property | Value | Property | Value |
---|---|---|---|
CYP1A2 inhibitor | 0.002 | CYP1A2 substrate | 0.682 |
CYP2A6 substrate | 0.618 | CYP2B6 substrate | 0.56 |
CYP2C19 inhibitor | 0.087 | CYP2C19 substrate | 0.899 |
CYP2C8 substrate | 0.722 | CYP2C9 inhibitor | 0.09 |
CYP2C9 substrate | 1.0 | CYP2D6 inhibitor | 0.027 |
CYP2D6 substrate | 0.85 | CYP2E1 substrate | 0.206 |
CYP3A4 inhibitor | 0.04 | CYP3A4 substrate | 0.984 |
Excretion
Property | Value | Property | Value |
---|---|---|---|
T1/2 | 0.827 | CL | 2.314 |
Toxicity
Property | Value | Property | Value |
---|---|---|---|
hERG Blockers | 0.009 | Hepatotoxicity | 0.467 |
Mutagenicity | 0.015 | Rat Oral Acute Toxicity | 0.221 |
FDAMDD | 0.449 | Skin Sensitization | 0.0 |
Carcinogenicity | 0.002 | Eye Corrosion | 0.007 |
Eye Irritation | 0.022 | Respiratory Toxicity | 0.113 |
Environmental Toxicity
Property | Value | Property | Value |
---|---|---|---|
Bioconcentration Factors | -0.541 | IGC50 | 1.866 |
LC50FM | 1.999 | LC50DM | 3.977 |
Tox21 Pathway
Property | Value | Property | Value |
---|---|---|---|
NR-AR | 0.44 | NR-AR-LBD | 0.271 |
NR-AhR | 0.005 | NR-Aromatase | 0.047 |
NR-ER | 0.395 | NR-ER-LBD | 0.416 |
NR-PPAR-gamma | 0.482 | SR-ARE | 0.066 |
SR-ATAD5 | 0.344 | SR-HSE | 0.187 |
SR-MMP | 0.009 | SR-p53 | 0.045 |
Similar covalent inhibitors
Similar covalent drugs
No similar covalent drugs found for this compound.